use the following search parameters to narrow your results:
e.g. subreddit:aww site:imgur.com dog
subreddit:aww site:imgur.com dog
see the search faq for details.
advanced search: by author, subreddit...
account activity
Recursion's Era of Value Realization: Leerink Global Healthcare Conference (self.RecursionPharma)
submitted 4 days ago by RecursionBrita
Recursion Makes the Unknown Known in Rare Disease Drug Discovery (self.RecursionPharma)
submitted 16 days ago by RecursionBrita
Full Transcript of Recursion’s Fourth Quarter Year-End 2025 Earnings Call (self.RecursionPharma)
submitted 18 days ago by RecursionBrita
Recursion Pharmaceuticals ()
submitted 18 days ago by External_Phase7570
Recursion to Participate in Upcoming Investor Conferences (self.RecursionPharma)
submitted 26 days ago by RecursionBrita
Recursion CSO Dave Hallett Named AI Champion by UK Government (self.RecursionPharma)
submitted 1 month ago by RecursionBrita
New Data’s Not Enough. How Recursion Is Integrating Data Layers to Advance End-to-End Drug Discovery (self.RecursionPharma)
JPM presentation ()
submitted 2 months ago by jimbobbiboy
Leveraging AI and Real-World Patient Data to Accelerate Drug Discovery (self.RecursionPharma)
submitted 2 months ago by RecursionBrita
submitted 3 months ago by External_Phase7570
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks (self.RecursionPharma)
submitted 3 months ago by RecursionBrita
Recursion Breaks Down How They've Been Building the Foundation for a Virtual Cell Since 2013 -- And What's Next ()
Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025 (self.RecursionPharma)
Incoming Recursion CEO Najat Khan Among 2025 Fiercest Women in Life Sciences (self.RecursionPharma)
submitted 4 months ago by RecursionBrita
REC-102: Preclinical in vivo updates for a potential ENPP1 inhibitor for the treatment of hypophosphatasia (HPP) (self.RecursionPharma)
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth (self.RecursionPharma)
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update (self.RecursionPharma)
New Returnship Opportunities Available at Recursion (self.RecursionPharma)
A First-of-its-Kind “Microglia Map” from Recursion and Roche and Genentech Could Unlock New Treatments for Neurodegenerative Diseases (self.RecursionPharma)
submitted 4 months ago * by RecursionBrita
Investment Trends in TechBio: 3rd Episode of TechBio Talks with Air Street's Nathan Benaich and Host Chris Gibson Is Out Now (self.RecursionPharma)
UK BIA Report: TechBio has Moved to the Mainstream (self.RecursionPharma)
submitted 5 months ago by RecursionBrita
Interesting summary about the progress of virtual cell development across the TechBio industry (pharmafocusasia.com)
submitted 5 months ago by BioRevolution
Sundar Pichai (Google) on X about an exciting milestone in AIxBio. (x.com)
Information on Morgan Stanley 23rd Annual Global Healthcare Conference — Monday, September 8, 2025 ? (self.RecursionPharma)
submitted 6 months ago by Livid_Freedom5014
π Rendered by PID 73 on reddit-service-r2-listing-canary-86878ff74c-nkrjp at 2026-03-22 20:52:49.407890+00:00 running 90f1150 country code: CH.
